Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Pharmaceutical industry news


From To
A powerful push for Gilead's patent in India

The US commerce secretary lobbying his counterpart in another country on behalf of a company is rare, but not unknown, and in early November, just days ahead of US President Barack Obama’s visit to India, Gary Locke did just that, writing to India’s Anand Sharma seeking “fair consideration” of Gilead Sciences Inc.’s patent appeal in India.

17 December 2010
SECTION27 and TAC applaud successful ARV medicine tender – but call for continued actions to drive prices of essential medicines down further

SECTION27 and TAC applaud the Minister of Health and his team at the Department of Health (DoH) for their part in conceptualising, implementing and concluding a successful antiretroviral (ARV) medicine tender.

16 December 2010
Treatment Action Campaign
South Africa to double HIV patient treatment

South Africa's health minister says he has brought down the cost of HIV drugs by 53 percent, enabling the government to treat twice as many patients in the next two years.

14 December 2010
Washington Post
S. African pharma Adcock's portion of ARV tender falls, shares drop

South African drug maker Adcock Ingram suffered a sharp drop in its share of a lucrative government HIV/AIDS drug supply contract, company figures showed on Tuesday, sending its share price down more than 5 percent.

14 December 2010
Deal spells doom for our chronically sick

"By sacrificing Africa, India could gain a bigger market in Europe for lifestyle diseases, while at the same time protecting its own products. This move confirms the truth in the adage — while India and the likes of Brazil chose to learn how to fish, we opted for handouts."

13 December 2010
Daily Nation (Nairobi)
Trade agreements should not hinder efforts towards universal access to HIV prevention, treatment, care and support

The Joint United Nations Programme on HIV/AIDS (UNAIDS) calls on all countries to ensure efforts towards universal access to HIV prevention, treatment, care and support are not impeded by bilateral and multilateral trade agreements.

09 December 2010
Abbott receives FDA approval for first automated molecular test for assessing hepatitis B treatment

Abbott announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.

01 September 2010

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.